Strides Pharma Science Limited (STAR) — Sustainability Report | 21 July 2026

Strides Pharma Science Limited submitted its Business Responsibility & Sustainability Report (BRSR) for FY25-26 on July 21, 2026, detailing ESG performance across 7 material themes identified via stakeholder assessment. The report covers environmental metrics like energy (44.19% renewable), water (190,297 KL withdrawn), waste (1,910 MT generated), and GHG emissions (Scope 1: 6,542 MT CO2e; Scope 2: 18,838 MT CO2e), alongside social disclosures on employee welfare (0.44% revenue spent on well-being), diversity (16% female wages), and community CSR initiatives benefiting 14,228+ people. Governance highlights include Board-approved policies, DNV-verified disclosures, and stakeholder engagement frameworks. No material ESG risks were identified beyond product quality, human rights, and geopolitical instability, with proactive mitigation strategies outlined.